Ls Investment Advisors, LLC Biomarin Pharmaceutical Inc Transaction History

Ls Investment Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 10, 2020	SELL	$79.55 - $124.22 $20,523 - $32,048	-258 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$71.37 - $96.85 $59,379 - $80,579	-832 Reduced 76.33%	258 $22,000
Q4 2018 Feb 01, 2019	SELL	$80.14 - $106.07 $28,930 - $38,291	-361 Reduced 24.88%	1,090 $93,000
Q3 2017 Oct 19, 2017	BUY	$80.6 - $94.95 $116,950 - $137,772	1,451	1,451 $135,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.